A deal with Sandoz to lead the global launch of Pear's two lead products puts marketing muscle behind the nascent class of 'prescription digital therapeutics.'
Despite the US Congress's lack of insight into Facebook's operations, Mark Zuckerberg's handling of the situation seems to have restored investor confidence in the company.
Scott Dulitz, SVP, Corporate Strategy, Business Development for TrialCard, outlines how embracing the modern hub allows brands to reach their full potential.
With healthcare evolving from a fee-for-service system toward one that bases payment on outcomes, marketers must speak to customers in value-oriented messages.
AI, wearables, and VR still reign supreme in the healthcare realm, and other things you missed
Caregivers and patients predict how the use of AI will affect them.
Philip Thomas takes over from Terry Savage.
AI's marketing problem: Inflated claims, outsized expectations may actually be slowing AI's move into clinical practiceMarch 21, 2018
The potential is real, but companies and technology gurus often speak of machine learning as a catch-all solution. The hype may be slowing AI's incremental growth in healthcare, experts say.
MM&M has announced its annual showcase of executives, investors, entrepreneurs, designers and thinkers who are ushering the industry into its new technological golden era.
MM&M spoke with Gazzaley about what's next for Akili, how he defines "digital medicine," and where the field is currently positioned on the hype cycle.
Want to get an ethicist agitated? Mention the integration of voice-activation and other tech into healthcare. Experts say navigating this area is a work in progress.
From Muse: Michelle Obama on making consumers comfortable with med tech (and thinking before she tweets)February 28, 2018
The former first lady spoke at Klick Health's Muse event, which also featured panels on gene therapy, health technology, and immunotherapy.
Heal CEO Nick Desai aims to improve the patient experience by providing an on-demand service that cuts time and costs while increasing human interaction.
Virta Health CEO Sami Inkinen on changing patient behavior: 'We're cutting down trees in the wrong forest'February 23, 2018
Seven questions for the Virta Health chief executive and cofounder of Trulia.
Zimprich joins from Honeywell, where he led global business communications.
Fueled by system-wide demand and facilitated by AI, the industry's lofty expectations around real-world evidence could soon be fulfilled
Amazon's ability to attract other employers makes its healthcare coalition very formidable, experts sayFebruary 01, 2018
Details are vague, but the e-commerce giant indicated it's serious about getting into healthcare.
Advertisers have until July to get their mobile pages up to speed.
Celgene reportedly in talks to buy Juno; Novartis' Kymriah receives fast-track reviews in U.S. and Europe; BI's Gilotrif gets expanded approval in lung cancer
The tech that's most likely to survive post-CES hype is voice but brands should rethink their gendered approach.
New research calls into question the behavioral effects of some digital health tools.
Novartis Oncology taps Pfizer exec as CEO; healthcare jobs become the largest source of U.S. employment; HHS nominee wary about drug-pricing negotiations
Maker of Botox biosimilar Evolus files IPO; pharma execs expect major acquisitions in 2018; J&J and Bayer win Xarelto reversal verdict
In the absence of behemoths such as Facebook and Twitter, pharma is partnering with China's tech giants to snare a slice of a more than $100 billion market
MM&M is calling for nominations for the 2018 class of Top 40 Healthcare Transformers and is seeking industry input for the Top 10 Innovation Catalysts.
US bank JPMorgan Chase has returned to advertising on YouTube only after developing its own algorithm that ensures its ads are not placed around questionable content.
Digital innovation in Japan, health-tech trends, and social media top the list.
Mallinckrodt to buy Sucampo for $1.2 billion; Amazon pushes digital advertising in 2018; WHO classifies gaming disorder as mental health condition
From gift bans to Google Assistant, POC to OPDP, MM&M staff members give their predictions on what to expect in healthcare marketing in 2018
Pharma R&D return on investment falls to eight-year low; FDA approves Pfizer's biosimilar to J&J's Remicade; Novartis to downsize generics business